Atlas Trials

Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy

Clinical trial NCT03355560 · COMPLETED

Trial details

NCT number
NCT03355560
Sponsor
Trisha Wise-Draper
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2017-12-06
Primary completion
2024-01-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.